Province/ |
Hepatitis B |
Varicella |
Meningococcal Conjugate |
(Menactra - Groups A, C, Y, W-135 conjugate |
Pneumococcal |
BC |
High risk people of all ages, contacts of cases |
|
High risk < 5 yrs, children with asplenia < 17 yrs |
||
AB |
High risk susceptible individuals, susceptible individuals aged 13 years and older |
Contacts of cases, high risk, laboratory workers. |
High risk 2-55 yr olds |
High risk and presumed high risk 2-59 mths, healthy aboriginal children up to 59 mths, children with asplenia aged 2 mths-16 yrs |
|
SK |
Selected high risk susceptible people |
High risk, close contacts |
High risk > 2 yrs |
High risk < 5 yrs |
|
MB |
Selected criteria (3 doses) |
High risk, susceptible household contacts of high risk susceptible clients |
High risk ≥ 2 mths |
High risk 2-55 yr olds |
High risk < 5 yrs |
ON |
Susceptible high risk people of all ages |
High risk all ages, close contacts of cases |
|
High risk < 5 yrs |
|
QC |
Susceptible people of all ages |
Contacts of cases, high risk |
|
Non-immunized children < 5 yrs |
|
NB |
|
High risk all ages, contacts of cases |
Menactra in high risk groups >2yrs |
High risk < 5 yrs |
|
NS |
|
||||
PE |
High risk, contacts of cases |
|
High risk, presumed high risk |
||
NL |
Selected high risk susceptible people |
Contacts of cases, outbreak control |
High risk |
High risk < 9 yrs |
|
NT |
|
|
High risk < 2 yrs |
||
YT |
High risk ≥ 12 mths (1 dose) |
|
|||
NU |
|
Household contacts, outbreak control |
|
|
|
Original Source: Canadian Nursing Coalition on Immunization, 2004 |